Filgrastim Terminated Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00681044HD Melphalan and SCT in Patients With IGDD or LCDD